Fig 1.
Analysis of the Tisdale score before and after the hypothetical intervention of prescriptions (a), together with the serious cardiovascular ADE in percentage (b).
Serotonin syndrome (SS).
Fig 2.
Clinical management of medications prescribed in the ICU with the potential for serious adverse reactions caused at the cardiovascular level.
Table 1.
Descriptive analysis of sociodemographic and clinical variables of patients with COVID-19 from March to December 2020.
Table 2.
Variation in the prevalence ratio between the Tisdale scores related to QT interval prolongation in patients diagnosed with COVID-19 admitted to the ICU of a Brasilia reference hospital from March to December 2020. Systemic arterial hypertension (SAH); prevalence ratio (PR); 95% confidence interval (95%CI).